Stockscreener 앱 받기
9.275
3.47%
0.335
Clearpoint Neuro Inc 주식(CLPT)의 최신 뉴스
ClearPoint Neuro (NASDAQ:CLPT) Given New $18.00 Price Target at B. Riley Financial - MarketBeat
ClearPoint Neuro (CLPT) Target Price Lowered but Rating Maintained | CLPT Stock News - GuruFocus
ClearPoint Neuro price target lowered to $18 from $28 at B. Riley - TipRanks
CLPT SEC FilingsClearpoint Neuro Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Analysts Offer Insights on Healthcare Companies: ClearPoint Neuro (CLPT) and Journey Medical Corp (DERM) - The Globe and Mail
CLPT Technical Analysis & ETF Price Forecast - Intellectia AI
CLPT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
(CLPT) and the Role of Price-Sensitive Allocations - Stock Traders Daily
CEO-related trust at ClearPoint Neuro (CLPT) sells 19,951 shares under plan - Stock Titan
ClearPoint Neuro Inc. (CLPT) Stock Analysis: Uncovering a Potential 91% Upside in the Medical Device Sector - DirectorsTalk Interviews
VIX Spike: Can ClearPoint Neuro Inc reach all time highs this yearEntry Point & Intraday High Probability Alerts - baoquankhu1.vn
CLPT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
CLPT (NASDAQ: CLPT) Rule 144 filing lists vested RSAs/RSUs; January 10b5-1 sales - Stock Titan
CLS Q4 (Review): Low sales due to alignment discussions with ClearPoint Neuro - marketscreener.com
CLPTClearpoint Neuro Inc Latest Stock News & Market Updates - Stock Titan
Will ClearPoint Neuro Inc. be affected by tariffs2025 Retail Activity & Technical Buy Zone Confirmation - mfd.ru
Clearpoint Neuro Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView
CLPT (NASDAQ: CLPT) amendment lists 10b5-1 sale of 26,463 shares - Stock Titan
Published on: 2026-02-20 20:00:43 - baoquankhu1.vn
ClearPoint Neuro (CLPT) awards 147,275 restricted stock units to CEO Burnett - Stock Titan
ClearPoint Neuro (CLPT) to Release Earnings on Wednesday - MarketBeat
Responsive Playbooks and the CLPT Inflection - Stock Traders Daily
Will ClearPoint Neuro Inc. stock continue upward momentumJuly 2025 PreEarnings & Risk Managed Investment Strategies - mfd.ru
Is ClearPoint Neuro Inc. stock ready for breakout2025 Bull vs Bear & Free Accurate Trade Setup Notifications - mfd.ru
Pullback Watch: What are ClearPoint Neuro Incs recent SEC filings showing2025 Price Momentum & Daily Profit Focused Stock Screening - baoquankhu1.vn
ClearPoint Neuro Inc. (CLPT): Investor Outlook Reveals 116.90% Potential Upside In Medical Devices Sector - DirectorsTalk Interviews
Is ClearPoint Neuro Inc. stock forming a cup and handle2025 Trade Ideas & Weekly Market Pulse Updates - mfd.ru
ClearPoint Neuro shares advance after securing EU MDR approval - MSN
Essex Investment Management Co. LLC Sells 92,920 Shares of ClearPoint Neuro, Inc. $CLPT - MarketBeat
Published on: 2026-02-07 14:18:50 - baoquankhu1.vn
Aug Big Picture: What chart patterns are forming on Cavco Industries IncDividend Hike & Growth Focused Entry Reports - baoquankhu1.vn
Earnings Risk: What is GCTSWSs valuation compared to sectorQuarterly Growth Report & Step-by-Step Trade Execution Guides - baoquankhu1.vn
Understanding the Setup: (CLPT) and Scalable Risk - Stock Traders Daily
ClearPoint Neuro Inc. (CLPT) Stock Analysis: Exploring a 117.88% Potential Upside in the Medical Devices Sector - DirectorsTalk Interviews
US Market Wrap: What are ClearPoint Neuro Incs recent SEC filings showingQuarterly Trade Review & Growth Focused Entry Point Reports - baoquankhu1.vn
ClearPoint Neuro expands team to over 170 focused on Neuro - Traders Union
Painful Week for Individual Investors Invested in ClearPoint Neuro, Inc. (NASDAQ:CLPT) After 18% Drop, Institutions Also Suffered Losses - 富途牛牛
ClearPoint Neuro (NASDAQ:CLPT shareholders incur further losses as stock declines 18% this week, taking five-year losses to 47% - simplywall.st
Published on: 2026-01-30 00:59:02 - baoquankhu1.vn
ClearPoint Neuro Inc. (CLPT) Stock Analysis: Is A 115.93% Upside On The Horizon? - DirectorsTalk Interviews
Insider Selling: ClearPoint Neuro (NASDAQ:CLPT) CEO Sells $45,822.51 in Stock - MarketBeat
CLPT Gets EU MDR Certification for ClearPoint Navigation Software - Finviz
ClearPoint Neuro: From Validation To Scale (NASDAQ:CLPT) - Seeking Alpha
Market Review: Can NextPlat Corp Equity Warrant outperform under higher oil pricesRisk Management & Growth Focused Investment Plans - baoquankhu1.vn
Quarterly Earnings: Will Georgia Power Company Preferred Security be affected by tariffsBreakout Watch & Growth Oriented Trade Recommendations - baoquankhu1.vn
The Technical Signals Behind (CLPT) That Institutions Follow - Stock Traders Daily
ClearPoint Neuro Gets EU Green Light For Updated Brain Surgery Software - Sahm
ClearPoint Neuro receives EU MDR certification for navigation software By Investing.com - Investing.com Australia
ClearPoint Neuro stock rises after receiving EU MDR certification By Investing.com - Investing.com South Africa
ClearPoint Neuro stock rises after receiving EU MDR certification - Investing.com
ClearPoint Neuro Announces EU MDR Certification for ClearPoint Navigation Software Version 3.0.2, Expanding Access to the Latest Operating Room Navigation Platform in Europe - BioSpace
ClearPoint Neuro receives EU MDR certification for navigation software - Investing.com
New brain surgery software opens CT-guided option for hospitals without MRI - Stock Titan
2.56%
자본화:
|
볼륨(24시간):